BTRC and cancer: This has been demonstrated for FBXW family members in neoplastic and inflammatory biology especially, with FBXW1 (also known as the beta transferrin repeat containing protein (β-trcp1)) and FBXW7 identified as likely oncogenes [13–15] whose deficiency or mutation is associated with multiple forms of cancer.